Industry Intelligence / BD SCREENING

BD Opportunity Screening (Hypotheses)

Based only on selected ClinicalTrials.gov registrations, generate source-cited BD research questions. These are unverified hypotheses, not deal leads or proven licensing opportunities.

01Screen NCT candidates

02Identify evidence gaps

03Generate hypotheses for diligence

Evidence standard · Registry-backed · US source

Coverage: ClinicalTrials.gov only, currently queried live. Other national registries, patents, company disclosures and commercial databases are not merged.

Find research candidates to review

Only the displayed page of matches is shown. This is not a global trial census.

BD hypothesis review board

Screen trial registrations for human follow-up. A sponsor is not proof of IP ownership, licensing intent, deal availability or regulatory approval.

Due diligence required

Required independent checksAsset and patent ownershipDisclosed partnerships and licensing restrictionsCompany contact and willingness to discussRegulatory record, clinical outcomes and commercial value

Choose up to 8 records for an AI hypothesis report · selected 0/8

No verified commercial lead, score or partnership claim is generated here.

Search for an asset or topic above, then pick candidates for an evidence-gap review.

Shared intelligence toolsOptional registry watchlists, projects, FDA application lookup, company teamwork and source coverage are available here for all three analyses.